Literature DB >> 7557861

Portal hypertension and iron depletion in patients with genetic hemochromatosis.

A L Fracanzani1, S Fargion, R Romano, D Conte, A Piperno, R D'Alba, C Mandelli, M Fraquelli, S Pacchetti, M Braga.   

Abstract

Clinically, portal hypertension has been considered to be less common and less severe in patients with cirrhosis resulting from iron overload in homozygotes for genetic hemochromatosis than in patients with cirrhosis of other causes. To characterize the prevalence and progression of portal hypertension in genetic hemochromatosis (GH), 120 cirrhosis and iron-overloaded patients were compared with a control group of 120 patients with postnecrotic cirrhosis (PNC) who were matched for gender, age, Child's class, and alcohol abuse. Gastroesophageal endoscopy and abdominal ultrasonography were performed at diagnosis and repeated every 12 months and every 6 months, respectively, to evaluate the presence and severity of varices, the caliber of the portal vein and its collaterals, and splenic size. At diagnosis a similar frequency of varices was observed in patients with GH (25%) and in PNC (24%), as well as of portal vein abnormalities and spleen enlargement. During the follow-up period, all but two of the patients with GH were treated by phlebotomy and depleted of excess iron. After a mean of 6 +/- 4.3 (SD) years of observations (range, 2 to 10 years), varices were improved or completely reversed in 26% of patients with cirrhosis and GH but in only 5% of those with PNC (P < .01). Bleeding from varices was observed in only one patient with GH but in five patients with PNC. Of 22 patients with GH in whom portal hypertension was unmodified or worsened, 16 had coexistent hepatic viral infection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557861     DOI: 10.1002/hep.1840220417

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  The diagnosis and management of hereditary haemochromatosis.

Authors:  Paul Clark; Laurence J Britton; Lawrie W Powell
Journal:  Clin Biochem Rev       Date:  2010-02

2.  The global burden of iron overload.

Authors:  Marnie J Wood; Richard Skoien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2009-07-29       Impact factor: 6.047

3.  [Molecular genetic analysis and clinical aspects of patients with hereditary hemochromatosis].

Authors:  U Lange; J Teichmann; G Dischereit
Journal:  Orthopade       Date:  2014-08       Impact factor: 1.087

Review 4.  Liver cirrhosis.

Authors:  Detlef Schuppan; Nezam H Afdhal
Journal:  Lancet       Date:  2008-03-08       Impact factor: 79.321

Review 5.  Diagnosis and Treatment of Genetic HFE-Hemochromatosis: The Danish Aspect.

Authors:  Nils Thorm Milman; Frank Vinholt Schioedt; Anders Ellekaer Junker; Karin Magnussen
Journal:  Gastroenterology Res       Date:  2019-10-04

Review 6.  Iron-Induced Liver Injury: A Critical Reappraisal.

Authors:  Steven A Bloomer; Kyle E Brown
Journal:  Int J Mol Sci       Date:  2019-04-30       Impact factor: 5.923

7.  Cellular calcium in bipolar disorder: systematic review and meta-analysis.

Authors:  Paul J Harrison; Nicola Hall; Arne Mould; Noura Al-Juffali; Elizabeth M Tunbridge
Journal:  Mol Psychiatry       Date:  2019-12-04       Impact factor: 15.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.